Skip to main content
NCBI home page
Breast Cancer Research : BCR logoLink to Breast Cancer Research : BCR
. 2024 Nov 26;26:164. doi: 10.1186/s13058-024-01929-z

Correction: Differentiating HER2-low and HER2-zero tumors with 21-gene multigene assay in 2,295 HR + HER2- breast cancer: a retrospective analysis

Yoonwon Kook 1,2,#, Young-jin Lee 3,#, Chihhao Chu 1,2,#, Ji Soo Jang 1,2, Seung Ho Baek 1,2, Soong June Bae 1,2, Yoon Jin Cha 2,4, Gyungyup Gong 5, Joon Jeong 1,2, Sae Byul Lee 3,✉, Sung Gwe Ahn 1,2,✉
PMCID: PMC11590534  PMID: 39593071

Correction to: Kook et al. Breast Cancer Research (2024) 26:154

10.1186/s13058-024-01911-9

Following the publication of the original article, the authors reported an error in the title due to typesetting mistake. HR + was wrongly typeset as h+.

The title of this Correction is correct, and the original article has been corrected.

Footnotes

The online version of the original article can be found at 10.1186/s13058-024-01911-9.

Publisher’s note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Yoonwon Kook, Young-jin Lee, and Chihhao Chu have contributed equally to this work.

Contributor Information

Sae Byul Lee, Email: newstar153@hanmail.net.

Sung Gwe Ahn, Email: asg2004@yuhs.ac.

Articles from Breast Cancer Research : BCR are provided here courtesy of BMC

RESOURCES